Adeona Pharmaceuticals Common Stock News - AEN

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT...

- Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Amendment No. __)* Under the...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of...

Company News for December 01, 2011 - Corporate Summary

• Jos. A. Bank (NASDAQ:JOSB) posted Q3 EPS of $0.54, higher than the Zacks Consensus Estimate of $0.51 per share...

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator -- PNA Center for Neurological Research Clinical Study...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One...

Adeona Reports Third Quarter 2011 Financial Results

Adeona Reports Third Quarter 2011 Financial Results -- Clinical Trial for Cognitive Dysfunction in Multiple Sclerosis Recruiting Patients -- PR...

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research PR Newswire ANN ARBOR, Mich., Nov. 11, 2011 ANN ARBOR...

Adeona to Host Third Quarter 2011 Investor Conference Call

Adeona to Host Third Quarter 2011 Investor Conference Call -- Conference Call Scheduled for Monday, November 14, 2011, at 2:00pm EST -- PR...

Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting

Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting - Diana Pollock, M.D., to...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Adeona Pharmaceuticals Common Stock (AEN)

Professional-Grade Tools, for Individual Investors.

AEN News

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

Company News for December 01, 2011 - Corporate Summary

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...

- Current report filing (8-K)

- Quarterly Report (10-Q)

Adeona Reports Third Quarter 2011 Financial Results

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research

Adeona to Host Third Quarter 2011 Investor Conference Call

Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting

AEN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Adeona Pharmaceuticals Common Stock (AEN) News

Adeona Pharmaceuticals Common Stock (AEN)

Professional-Grade Tools, for Individual Investors.

AEN News

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Statement of Beneficial Ownership (SC 13D)

- Current report filing (8-K)

Company News for December 01, 2011 - Corporate Summary

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...

- Current report filing (8-K)

- Quarterly Report (10-Q)

Adeona Reports Third Quarter 2011 Financial Results

Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research

Adeona to Host Third Quarter 2011 Investor Conference Call

Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting

AEN Discussion

Your Recent History